[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368876-105":59,"doc-detail-368876-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cimt-2025-report-on-the-22nd-annual-meeting-of-the-association-for-cancer-immunotherapy","CIMT 2025 - Report on the 22nd Annual Meeting of the Association for Cancer Immunotherapy","","CIMT 2025 was held May 12–14, 2025, in Mainz, Germany, bringing together 674 academic and clinical professionals from 27 countries. The meeting served as a central forum for cancer immunotherapy, enabling in-depth discussion of recent advances in cancer immunology and immunotherapy. Sessions addressed the relationship between the nervous and immune systems in cancer and the use of artificial intelligence to understand antigen receptor recognition of tumor antigens. The report summarizes key highlights and takeaways from CIMT2025.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cimt-2025-report-on-the-22nd-annual-meeting-of-the-association-for-cancer-immunotherapy/368876/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cimt-2025-report-on-the-22nd-annual-meeting-of-the-association-for-cancer-immunotherapy/368876.png","ImageObject",300,407,{"name":92,"@type":93},"Mary Man","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"When and where was CIMT 2025 held?","Question",{"text":112,"@type":113},"CIMT 2025 took place from May 12 to May 14, 2025, in Mainz, Germany.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many professionals and countries participated in the meeting?",{"text":117,"@type":113},"The meeting brought together 674 academic and clinical professionals from 27 countries across five continents.",{"name":119,"@type":110,"acceptedAnswer":120},"What research themes were highlighted in dedicated sessions?",{"text":121,"@type":113},"Sessions covered the interplay between the nervous and immune systems in cancer and the application of artificial intelligence to understand how antigen receptors recognize tumor antigens.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368876,1791308005,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7421720224475,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","HUMAN VACCINES & IMMUNOTHERAPEUTICS 2025, VOL. 21, NO. 1, 2563962 [https://doi.org/10.1080/21645515.2025.2563962](https://doi.org/10.1080/21645515.2025.2563962)  \nMEETING REPORT     \nCIMT 2025: Report on the 22nd Annual Meeting of the Association for Cancer Immunotherapy  \nLia Dahla, Johanna Kieferb, Laura Kleinb, Sophie-Christin Linkenbachc, Anindhita Meena Muralidharanc, Matthias Peterc, Nina Tagschererc, and Jan D. Beck b  \naBioNTech Cell & Gene Therapies GmbH, Mainz, Germany; bBioNTech SE, Mainz, Germany; cTRON-Translational Oncology, University Medical Center of Johannes Gutenberg University Mainz gGmbH, Mainz, Germany  \nABSTRACT  \nThe 22nd Annual Meeting of the Association for Cancer Immunotherapy (CIMT) was held from May 12 to May 14, 2025, in Mainz, Germany. The event brought together 674 academic and clinical professionals from 27 countries across five continents. As a central forum for the global cancer immunotherapy community, the meeting facilitated indepth discussions on the most recent advances in cancer immunology and immunotherapy. Dedicated sessions explored cutting-edge topics such as the interplay between the nervous and immune systems in cancer, as well as the application of artificial intelligence to decipher how antigen receptors recognize tumor antigens – insights that are shaping the development of next-generation immunotherapies. This report offers a summary of the most significant highlights and key takeaways from CIMT2025 .  \nARTICLE HISTORY  \nReceived 2 September 2025 Accepted 17 September 2025  \nKEYWORDS  \nCIMT; cancer immunotherapy; cellular therapy; tumor microenvironment; personalized therapy  \nIntroduction  \nThe 22nd Annual Meeting of the Association for Cancer Immunotherapy (CIMT) was held from May 12 to May 14, 2025, in Mainz, Germany. The event brought together 674 academic and clinical professionals from 27 countries across five continents. As a central forum for the global cancer immunotherapy community, the meeting facilitated in-depth discussions on the most recent advances in cancer immunology and immunotherapy. Dedicated sessions explored cutting-edge topics such as the interplay between the nervous and immune systems in cancer, as well as the application of artificial intelligence to decipher how antigen receptors recognize tumor antigens – insights that are shaping the development of next-generation immunotherapies. This report offers a summary of the most significant highlights and key takeaways from CIMT2025 .  \nTumor microenvironment  \nBarbara Maier (CeMM Vienna, Austria) opened the 22nd CIMT Annual Meeting by discussing tumordraining (TD) lymph nodes (LN)s as premetastatic niches and their role in modulating anti-tumor immunity. TDLNs undergo stromal and immunosuppressive reprogramming in response to tumorderived signals, yet the spatial and cellular consequences remain poorly understood. Using an orthotopic oral carcinoma mouse model, her team applied imaging mass cytometry and single-cell RNA-sequencing (scRNA-seq) on TDLNs to map longitudinal changes. As tumors progressed, myeloid cell infiltration increased, their proximity to T cells decreased, and T cell density decreased with more fragmented T cell zones. Further characterization of infiltrating myeloid cells identified an Interleukin (IL)-1βhi monocyte population, absent in naïve LNs, which expressed markers indicating immunosuppressive potential. This signature was also found in human oral cancer TDLNs, indicating translational relevance. Manual LN domain annotation showed preferential localization of these monocytes to lymphatic areas. While dendritic cells (DC)s and stromal cells increased in T cell zones, tri-cellular interactions between proliferating T cells, monocytes, and lymphatic endothelial cells were enriched in the lymphatic domain. Cellular neighborhood  \nCONTACT Jan D. Beck  [beck@cimt.eu](beck@cimt.eu)  BioNTech SE, An der Goldgrube 12, Mainz 55131, Germany.  \n© 2025 The Author(s) . Published with license ","cbCailfUEql031Tz","https://ap.wps.com/l/cbCailfUEql031Tz","pdf",408740,13,"English","# Meeting Report\n## CIMT 2025 Overview\n## Tumor microenvironment","[{\"question\":\"When and where was CIMT 2025 held?\",\"answer\":\"CIMT 2025 took place from May 12 to May 14, 2025, in Mainz, Germany.\"},{\"question\":\"How many professionals and countries participated in the meeting?\",\"answer\":\"The meeting brought together 674 academic and clinical professionals from 27 countries across five continents.\"},{\"question\":\"What research themes were highlighted in dedicated sessions?\",\"answer\":\"Sessions covered the interplay between the nervous and immune systems in cancer and the application of artificial intelligence to understand how antigen receptors recognize tumor antigens.\"}]","CIMT 2025 - Report on the 22nd Annual Meeting of the Association for Cancer Immunotherapy | PDF",1790179039,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a31b98a64eb85132629e7389ced9365.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ca7d9c8545d891429d2068b6ea93fbb.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/306ce960198b7971fe85e775aa5c2864.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6e9402e82f5124d37032322108e83ec.webp",980,1306]